Dai XX - Search Results

1

Overexpression of miR-221 is associated with aggressive clinicopathologic characteristics and the BRAF mutation in papillary thyroid carcinomas.

Zhou YL, Liu C, Dai XX, Zhang XH, Wang OC. Zhou YL, et al. Among authors: dai xx. Med Oncol. 2012 Dec;29(5):3360-6. doi: 10.1007/s12032-012-0315-8. Epub 2012 Aug 2. Med Oncol. 2012. PMID: 22855362

2

The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma.

Lin KL, Wang OC, Zhang XH, Dai XX, Hu XQ, Qu JM. Lin KL, et al. Among authors: dai xx. Ann Surg Oncol. 2010 Dec;17(12):3294-300. doi: 10.1245/s10434-010-1129-6. Epub 2010 Oct 15. Ann Surg Oncol. 2010. PMID: 20953721

3

[Screening of high-risk patients with papillary thyroid microcarcinoma by preoperative BRAF gene-mutation detection].

Lin KL, Zhang XH, Dai XX. Lin KL, et al. Among authors: dai xx. Zhonghua Zhong Liu Za Zhi. 2011 Feb;33(2):130-1. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 21575483 Chinese. No abstract available.

4

Preoperative BRAF mutation is predictive of occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma.

Zhou YL, Zhang W, Gao EL, Dai XX, Yang H, Zhang XH, Wang OC. Zhou YL, et al. Among authors: dai xx. Asian Pac J Cancer Prev. 2012;13(4):1267-72. doi: 10.7314/apjcp.2012.13.4.1267. Asian Pac J Cancer Prev. 2012. PMID: 22799316 Free article.

5

Effectiveness of OK-432 (Sapylin) to reduce seroma formation after axillary lymphadenectomy for breast cancer.

Yang Y, Gao E, Liu X, Ye Z, Chen Y, Li Q, Qu J, Dai X, Wang O, Pan Y, Zhang X. Yang Y, et al. Ann Surg Oncol. 2013 May;20(5):1500-4. doi: 10.1245/s10434-012-2728-1. Epub 2012 Oct 28. Ann Surg Oncol. 2013. PMID: 23104710 Clinical Trial.

6

Co-expression networks revealed potential core lncRNAs in the triple-negative breast cancer.

Yang F, Liu YH, Dong SY, Yao ZH, Lv L, Ma RM, Dai XX, Wang J, Zhang XH, Wang OC. Yang F, et al. Among authors: dai xx. Gene. 2016 Oct 15;591(2):471-7. doi: 10.1016/j.gene.2016.07.002. Epub 2016 Jul 2. Gene. 2016. PMID: 27380926

7

Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer.

Yang F, Lv SX, Lv L, Liu YH, Dong SY, Yao ZH, Dai XX, Zhang XH, Wang OC. Yang F, et al. Among authors: dai xx. Onco Targets Ther. 2016 Nov 15;9:7039-7045. doi: 10.2147/OTT.S110055. eCollection 2016. Onco Targets Ther. 2016. PMID: 27895496 Free PMC article.

8

Curcuminoid EF24 enhances the anti-tumour activity of Akt inhibitor MK-2206 through ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction in gastric cancer.

Chen X, Dai X, Zou P, Chen W, Rajamanickam V, Feng C, Zhuge W, Qiu C, Ye Q, Zhang X, Liang G. Chen X, et al. Br J Pharmacol. 2017 May;174(10):1131-1146. doi: 10.1111/bph.13765. Epub 2017 Apr 6. Br J Pharmacol. 2017. PMID: 28255993 Free PMC article.

9

(S)-crizotinib induces apoptosis in human non-small cell lung cancer cells by activating ROS independent of MTH1.

Dai X, Guo G, Zou P, Cui R, Chen W, Chen X, Yin C, He W, Vinothkumar R, Yang F, Zhang X, Liang G. Dai X, et al. J Exp Clin Cancer Res. 2017 Sep 7;36(1):120. doi: 10.1186/s13046-017-0584-3. J Exp Clin Cancer Res. 2017. PMID: 28882182 Free PMC article.

10

Schisandrin B exhibits potent anticancer activity in triple negative breast cancer by inhibiting STAT3.

Dai X, Yin C, Guo G, Zhang Y, Zhao C, Qian J, Wang O, Zhang X, Liang G. Dai X, et al. Toxicol Appl Pharmacol. 2018 Nov 1;358:110-119. doi: 10.1016/j.taap.2018.09.005. Epub 2018 Sep 5. Toxicol Appl Pharmacol. 2018. PMID: 30195018

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters